Cerus Corporation (NASDAQ:CERS – Get Free Report) Director Eric Bjerkholt sold 20,454 shares of Cerus stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $2.60, for a total transaction of $53,180.40. Following the completion of the transaction, the director directly owned 261,679 shares of the company’s stock, […]

Xos, Inc. (NASDAQ:XOS – Get Free Report) Director Dietmar Ostermann sold 3,351 shares of the company’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $4.45, for a total value of $14,911.95. Following the completion of the transaction, the director directly owned 79,593 shares in the company, […]

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) Director John Johnson sold 15,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $6.09, for a total value of $91,350.00. Following the completion of the sale, the director directly owned 683,083 shares of the […]

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) Director Dawn Halkuff sold 20,000 shares of the stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $6.09, for a total transaction of $121,800.00. Following the completion of the sale, the director directly owned 95,000 shares of the […]

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) Director Marla Persky sold 15,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $5.90, for a total value of $91,450.00. Following the transaction, the director directly owned 126,500 shares in the company, valued […]